logo

For the Inventor, By the Inventor

Raleigh, NC, United States of America

Cynthia L Lichorowic

This inventor holds 9 USPTO granted patents and 3 published patent applications. Top assignees: Aerie Pharmaceuticals, Inc., Alcon, Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cynthia L Lichorowic. Retrieved from https://idiyas.com/inventor/cynthia-l-lichorowic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:

goldMedal8 out of 60 
 
Aerie Pharmaceuticals, Inc.
 patents
silverMedal1 out of 1,309 
 
Alcon, Inc.
 patents

Years Active: 2020-2025

Loading Chart...
9 patents (USPTO):Explore Patents
1. 12459956 - Heterobicyclic carboxamides and uses thereof (2025-11-04),
2. 12018012 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2024-06-25),
3. 11891376 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2024-02-06),
4. 11691950 - Isoquinoline-steroid conjugates and uses thereof (2023-07-04),
5. 11427563 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2022-08-30),
6. 11312700 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2022-04-26),
7. 11117869 - Compounds, compositions and methods for treatment of myopia (2021-09-14),
8. 11059789 - Isoquinoline-steroid conjugates and uses thereof (2021-07-13),
9. 10858339 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2020-12-08),

Certainly! Here is the article about inventor Cynthia L Lichorowic based on the data provided:

Title: Innovator Spotlight: Cynthia L Lichorowic - Pioneering Therapeutic Compounds

Introduction:

Cynthia L Lichorowic, a remarkable inventor based in Raleigh, NC, is making waves in the field of pharmaceuticals with her groundbreaking contributions. With a total of 8 patents to her name, Cynthia's work is revolutionizing the treatment of various diseases, from glaucoma to inflammatory conditions.

Latest Patents:

Cynthia's latest patents focus on aryl cyclopropyl-amino-isoquinolinyl amide compounds. These compounds play a crucial role in modulating the function of kinases within cells, making them invaluable as therapeutic agents. They have shown promising results in the treatment of a wide range of conditions, including eye diseases, cardiovascular ailments, cancers, and inflammatory disorders.

Career Highlights:

Currently affiliated with Aerie Pharmaceuticals, Inc., Cynthia L Lichorowic continues to drive innovation and excellence in the pharmaceutical industry. Her expertise and dedication have led to the development of cutting-edge therapeutic compounds that have the potential to improve countless lives.

Collaborations:

Throughout her career, Cynthia has collaborated with esteemed professionals in the field, including Mitchell Anthony deLong and Jill Marie Sturdivant. Together, they have worked tirelessly to advance the field of pharmaceuticals and bring innovative solutions to fruition.

Conclusion:

In conclusion, Cynthia L Lichorowic's passion for innovation and her relentless pursuit of excellence have established her as a leading figure in the world of pharmaceutical inventions. Her work not only showcases her exceptional talent but also underscores her commitment to improving healthcare outcomes for individuals worldwide.

If you need further assistance or more information, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…